These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28408633)

  • 1. Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.
    Castellaro M; Magliozzi R; Palombit A; Pitteri M; Silvestri E; Camera V; Montemezzi S; Pizzini FB; Bertoldo A; Reynolds R; Monaco S; Calabrese M
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1087-1095. PubMed ID: 28408633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
    Maranzano J; Dadar M; Rudko DA; De Nigris D; Elliott C; Gati JS; Morrow SA; Menon RS; Collins DL; Arnold DL; Narayanan S
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
    Chawla S; Kister I; Wuerfel J; Brisset JC; Liu S; Sinnecker T; Dusek P; Haacke EM; Paul F; Ge Y
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1223-30. PubMed ID: 27012298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
    Harrison DM; Li X; Liu H; Jones CK; Caffo B; Calabresi PA; van Zijl P
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1447-53. PubMed ID: 26939635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping.
    Kakeda S; Futatsuya K; Ide S; Watanabe K; Miyata M; Moriya J; Ogasawara A; Sato T; Narimatsu H; Okada K; Uozumi T; Liu T; Wang Y; Korogi Y
    Acad Radiol; 2015 Nov; 22(11):1427-32. PubMed ID: 26342769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes.
    Tazza F; Boffa G; Schiavi S; Lapucci C; Piredda GF; Cipriano E; Zacà D; Roccatagliata L; Hilbert T; Kober T; Inglese M; Costagli M
    AJNR Am J Neuroradiol; 2024 Aug; 45(8):1166-1174. PubMed ID: 38816021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Kaunzner UW; Kang Y; Zhang S; Morris E; Yao Y; Pandya S; Hurtado Rua SM; Park C; Gillen KM; Nguyen TD; Wang Y; Pitt D; Gauthier SA
    Brain; 2019 Jan; 142(1):133-145. PubMed ID: 30561514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.
    Chiang GC; Hu J; Morris E; Wang Y; Gauthier SA
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):467-472. PubMed ID: 29371258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.
    Beck ES; Sati P; Sethi V; Kober T; Dewey B; Bhargava P; Nair G; Cortese IC; Reich DS
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):459-466. PubMed ID: 29439120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
    Zhang Y; Gauthier SA; Gupta A; Chen W; Comunale J; Chiang GC; Zhou D; Askin G; Zhu W; Pitt D; Wang Y
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1629-35. PubMed ID: 27256856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic susceptibility contrast variations in multiple sclerosis lesions.
    Li X; Harrison DM; Liu H; Jones CK; Oh J; Calabresi PA; van Zijl PC
    J Magn Reson Imaging; 2016 Feb; 43(2):463-73. PubMed ID: 26073973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
    Kang Y; Schlyer D; Kaunzner UW; Kuceyeski A; Kothari PJ; Gauthier SA
    PLoS One; 2018; 13(8):e0201289. PubMed ID: 30091993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
    Mainero C; Louapre C; Govindarajan ST; Giannì C; Nielsen AS; Cohen-Adad J; Sloane J; Kinkel RP
    Brain; 2015 Apr; 138(Pt 4):932-45. PubMed ID: 25681411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Leukocortical Lesions in Multiple Sclerosis and Their Association with Physical and Cognitive Impairment: A Comparison of Conventional and Synthetic Phase-Sensitive Inversion Recovery MRI.
    Forslin Y; Bergendal Å; Hashim F; Martola J; Shams S; Wiberg MK; Fredrikson S; Granberg T
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):1995-2000. PubMed ID: 30262646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.
    Yao Y; Nguyen TD; Pandya S; Zhang Y; Hurtado Rúa S; Kovanlikaya I; Kuceyeski A; Liu Z; Wang Y; Gauthier SA
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):303-310. PubMed ID: 29242359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
    Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.